Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective

BackgroundFirst-generation somatostatin receptor ligands (fg-SRLs) represent the first-line medical treatment for acromegaly, recommended in patients with persistent disease after neurosurgery, or when surgical approach is not feasible. Despite the lack of strong recommendations from guidelines and...

Full description

Bibliographic Details
Main Authors: Federica Nista, Giuliana Corica, Lara Castelletti, Keyvan Khorrami, Claudia Campana, Francesco Cocchiara, Gabriele Zoppoli, Alessandro Prior, Diego Criminelli Rossi, Gianluigi Zona, Diego Ferone, Federico Gatto
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.677919/full